Rational Drug Design of G-Quartet DNA as Anti-Cancer Agents
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2841-2854
Author(s):
N. Jing, W. Sha, Y. Li, W. Xiong and D. J. Tweardy
Targeting Chk2 Kinase: Molecular Interaction Maps and Therapeutic Rationale
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2855-2872
Author(s):
Y. Pommier, O. Sordet, A. Rao, H. Zhang and K. W. Kohn
Targeting Transcription Factors for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2873-2887
Author(s):
M. S. Redell and D. J. Tweardy
Bacterial Toxins: Potential Weapons Against HIV Infection
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2909-2926
Author(s):
M. Alfano, C. Rizzi, D. Corti, L. Adduce and G. Poli
Ex Vivo Gene Transfer for Improvement of Transplanted Pancreatic Islet Viability and Function
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2927-2940
Author(s):
S. Van Linthout and P. Madeddu
Beyond Single Pathway Inhibition: MEK Inhibitors as a Platform for the Development of Pharmacological Combinations with Synergistic Anti-Leukemic Effects
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2779-2795
Author(s):
M. Milella, C. M. Precupanu, C. Gregorj, M. R. Ricciardi, M. T. Petrucci, S. M. Kornblau, A. Tafuri and M. Andreeff
Inflammation and Cancer: When NF-κB Amalgamates the Perilous Partnership
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
325-344
Author(s):
Marina A. Dobrovolskaia and Serguei V. Kozlov
Molecular Targets from VHL Studies into the Oxygen-Sensing Pathway
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
345-356
Author(s):
M. A. Maynard and M. Ohh
The Therapeutic Potential of 4-1BB (CD137) in Cancer
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
357-363
Author(s):
Kyung-Ok Nam, Woo J. Kang, Byoung S. Kwon, Sung J. Kim and Hyeon-Woo Lee
The MCM Complex: Its Role in DNA Replication and Implications for Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
365-380
Author(s):
Ming Lei